Glucagon-like peptide-1 analogues - an efficient therapeutic option for the severe insulin resistance of lipodystrophic syndromes: two case reports

BACKGROUND: Lipodystrophic syndromes are uncommon medical conditions which are normally associated with metabolic disorders, such as diabetes mellitus, dyslipidemia, and fatty liver disease. These complications are generally difficult to treat, particularly diabetes, due to severe insulin resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Joana, Lau, Eva, Carvalho, Davide, Freitas, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237351/
https://www.ncbi.nlm.nih.gov/pubmed/28086952
http://dx.doi.org/10.1186/s13256-016-1175-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237351/
https://www.ncbi.nlm.nih.gov/pubmed/28086952
http://dx.doi.org/10.1186/s13256-016-1175-1

Ejemplares similares